S68 Health Disparities and Epigenetics

Program: Symposia
Clinical/Translational Session
Sunday, March 8, 2015: 11:15 AM-12:45 PM
Room 30A (San Diego Convention Center)
**This session is eligible for CME credit**

Chair:
To Be Determined

Disclosure Not Provided: YMH

This symposium will explore the complex biological mechanisms that result in health inequities. One presentation will discuss the timing of entry of patients into the health care system with respect to complications in diabetes and how screening may help minimize disparities. Another presentation will discuss the broadening of genome-wide association studies from primarily populations of European descent to non-European cohorts and how this has expanded our understanding of the genetics underlying type 2 diabetes. Finally, we discuss data from research on the epigenetic regulation of cancer risk, more specifically DNA methylation patterns. This expansion of genome-wide association studies to include epigenetics adds insight into alleles associated with increased cancer risk in different populations. These three perspectives provide an overview of how understanding past experiences and testing can help minimize future disparities in health by addressing inequality in access and environmental exposure.

11:15 AM
Anne E Sumner, MD, Diabetes, Endocrinology, and Obesity Branch, NIDDK, NIH, Bethesda, MD
Nothing to Disclose: AES
11:45 AM
Jose Carlos Florez, MD, PhD, Center for Human Genetic Research and Diabetes Unit, Massachusetts General Hospital, Boston, MA
Nothing to Disclose: JCF
12:15 PM
Holger Heyn, PhD, Cancer Epigenetics and Biology Program (PEBC), Institut D’Investigacio Biomedica de Bellvitge (IDIBELL), Barcelona, Spain
Nothing to Disclose: HH
See more of: Symposia